HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 216 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $256 | -25.6% | 6,695 | +10.8% | 1.28% | +6.3% |
| Q4 2022 | $344 | -99.8% | 6,042 | +14.9% | 1.20% | +51.9% |
| Q3 2022 | $208,000 | -31.4% | 5,257 | -23.6% | 0.79% | -11.0% |
| Q2 2022 | $303,000 | +21.2% | 6,877 | +9.7% | 0.89% | +55.1% |
| Q1 2022 | $250,000 | -8.1% | 6,267 | -7.3% | 0.57% | +32.0% |
| Q4 2021 | $272,000 | -27.7% | 6,761 | -26.9% | 0.44% | -4.4% |
| Q3 2021 | $376,000 | -11.5% | 9,254 | -1.0% | 0.46% | -8.6% |
| Q2 2021 | $425,000 | -1.6% | 9,350 | -9.7% | 0.50% | +4.6% |
| Q1 2021 | $432,000 | +104.7% | 10,359 | -23.3% | 0.48% | +106.1% |
| Q3 2019 | $211,000 | – | 13,500 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRAN CAPITAL MANAGEMENT, L.P. | 1,506,473 | $61,283,000 | 5.13% |
| First Light Asset Management, LLC | 1,477,496 | $60,105,000 | 3.96% |
| SNYDER CAPITAL MANAGEMENT L P | 3,427,476 | $139,430,000 | 3.69% |
| DOHENY ASSET MANAGEMENT /CA | 80,400 | $3,271,000 | 2.34% |
| Redwood Investments, LLC | 619,766 | $25,212,000 | 2.11% |
| HighMark Wealth Management LLC | 53,341 | $2,170,000 | 1.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 60,170 | $2,448,000 | 1.38% |
| Third Security, LLC | 168,604 | $6,859,000 | 1.33% |
| Taylor Wealth Management Partners | 87,654 | $3,566,000 | 1.27% |
| Penn Capital Management Company, LLC | 290,394 | $11,813,000 | 1.19% |